Vitamin A is a nutritional supplement used to correct deficiencies when dietary intake is insufficient. It also helps prevent and treat vision problems like night blindness and xerophthalmia. Your body needs vitamin A for healthy vision, reproduction, cell growth, and immune function, and it works by protecting cells and supporting their growth.[2] Aquasol A is currently approved and in use across 11 indications[4].[1]
Aquasol A is one of 282 small molecule programs targeting Glaucoma. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
1931 competitors in COVID-19
Aquasol A
Spikevax
Bnt162b2
COVID-19 Vaccine
Biaxin
Stivarga
Aimovig
Aldactone
Nexavar
Singulair
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources
Details